(Q35932469)

11 August 2017

1 reference

title

Photodynamic therapy of age-related macular degeneration: History and principles (English)

1 reference

11 August 2017

1 reference

van den Bergh H

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Seminars in Ophthalmology

11 August 2017

published in

1 reference

11 August 2017

volume

16

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

181-200

1 reference

Activated Dyes as Antitumor Agents

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photodynamic destruction of human bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Murine pharmacokinetics and antitumor efficacy of the photodynamic sensitizer 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Measurement of the rate of uptake and subcellular localization of porphyrins in cells using fluorescence digital imaging microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Structure and biodistribution relationships of photodynamic sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photosensitization of red blood cell hemolysis by lutetium texaphyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Efficacy of antitumoral photodynamic therapy with hypericin: relationship between biodistribution and photodynamic effects in the RIF-1 mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photosensitizer targeting in photodynamic therapy. II. Conjugates of haematoporphyrin with serum lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

The role of lipoproteins in the delivery of tumour-targeting photosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Photodynamic targeting of human retinoblastoma cells using covalent low-density lipoprotein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

On the mechanism of the tumour-localising effect in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Correlation between site II-specific human serum albumin (HSA) binding affinity and murine in vivo photosensitizing efficacy of some Photofrin components

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Signaling pathways in cell death and survival after photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Dark induction of haem oxygenase messenger RNA by haematoporphyrin derivative and zinc phthalocyanine; agents for photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Increased transcription and translation of heme oxygenase in Chinese hamster fibroblasts following photodynamic stress or Photofrin II incubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

The time course of cutaneous porphyrin photosensitization in the murine ear

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Microtubule assembly inhibition by porphyrins and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Tumor destruction in photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Mechanisms of tumor necrosis induced by photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

The microvascular effects of photodynamic therapy: evidence for a possible role of cyclooxygenase products

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Closure of experimental subretinal neovascular vessels with dihematoporphyrin ether augmented argon green laser photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

A new method for vascular occlusion. Photochemical initiation of thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Effects of light and darkness on oxygen distribution and consumption in the cat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FSOPH.16.4.181.10299

10.1076/SOPH.16.4.181.10299

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference